Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17792887 | Published Date: 24-Mar-2021 | No. of pages: 96
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Mammalian Based Manufacturing 1.2.3 Microbial Based Manufacturing 1.2.4 Other 1.3 Market by Application 1.3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Bio-Pharmaceutical Companies 1.3.3 Pharmaceutical Companies 1.3.4 Drug Discovery Companies 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Perspective (2016-2027) 2.2 Biopharmaceutical Contract Manufacturing(BCMO) Growth Trends by Regions 2.2.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Share by Regions (2016-2021) 2.2.3 Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2022-2027) 2.3 Biopharmaceutical Contract Manufacturing(BCMO) Industry Dynamic 2.3.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Trends 2.3.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers 2.3.3 Biopharmaceutical Contract Manufacturing(BCMO) Market Challenges 2.3.4 Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue 3.1.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue (2016-2021) 3.1.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Players (2016-2021) 3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing(BCMO) Revenue 3.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio 3.4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2020 3.5 Biopharmaceutical Contract Manufacturing(BCMO) Key Players Head office and Area Served 3.6 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service 3.7 Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Type 4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Type (2016-2021) 4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2022-2027) 5 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Application 5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Application (2016-2021) 5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027) 6.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type 6.2.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) 6.2.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) 6.2.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027) 6.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application 6.3.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) 6.3.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) 6.3.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027) 6.4 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country 6.4.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) 6.4.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027) 7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type 7.2.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) 7.2.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) 7.2.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027) 7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application 7.3.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) 7.3.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) 7.3.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027) 7.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country 7.4.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) 7.4.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027) 8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type 8.2.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027) 8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application 8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027) 8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region 8.4.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027) 9.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type 9.2.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) 9.2.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) 9.2.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027) 9.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application 9.3.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) 9.3.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) 9.3.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027) 9.4 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country 9.4.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) 9.4.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027) 10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type 10.2.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027) 10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application 10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027) 10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country 10.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Lonza Group Ltd 11.1.1 Lonza Group Ltd Company Details 11.1.2 Lonza Group Ltd Business Overview 11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.1.5 Lonza Group Ltd Recent Development 11.2 Boehringher Ingelheim 11.2.1 Boehringher Ingelheim Company Details 11.2.2 Boehringher Ingelheim Business Overview 11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.2.5 Boehringher Ingelheim Recent Development 11.3 Sandoz 11.3.1 Sandoz Company Details 11.3.2 Sandoz Business Overview 11.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.3.5 Sandoz Recent Development 11.4 Fujifilm Diosynth Biotechnology 11.4.1 Fujifilm Diosynth Biotechnology Company Details 11.4.2 Fujifilm Diosynth Biotechnology Business Overview 11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.4.5 Fujifilm Diosynth Biotechnology Recent Development 11.5 Rentschler Biotechnologie 11.5.1 Rentschler Biotechnologie Company Details 11.5.2 Rentschler Biotechnologie Business Overview 11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.5.5 Rentschler Biotechnologie Recent Development 11.6 Celonic GmbH 11.6.1 Celonic GmbH Company Details 11.6.2 Celonic GmbH Business Overview 11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.6.5 Celonic GmbH Recent Development 11.7 BIOMEVA GmbH 11.7.1 BIOMEVA GmbH Company Details 11.7.2 BIOMEVA GmbH Business Overview 11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.7.5 BIOMEVA GmbH Recent Development 11.8 ProBioGen AG 11.8.1 ProBioGen AG Company Details 11.8.2 ProBioGen AG Business Overview 11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Introduction 11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) 11.8.5 ProBioGen AG Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Mammalian Based Manufacturing Table 3. Key Players of Microbial Based Manufacturing Table 4. Key Players of Other Table 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2016-2021) Table 9. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2022-2027) Table 11. Biopharmaceutical Contract Manufacturing(BCMO) Market Trends Table 12. Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers Table 13. Biopharmaceutical Contract Manufacturing(BCMO) Market Challenges Table 14. Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints Table 15. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players (2016-2021) Table 17. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2020) Table 18. Ranking of Global Top Biopharmaceutical Contract Manufacturing(BCMO) Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing(BCMO) Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service Table 22. Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 25. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2016-2021) Table 26. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2016-2021) Table 30. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 33. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million) Table 35. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million) Table 62. Lonza Group Ltd Company Details Table 63. Lonza Group Ltd Business Overview Table 64. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product Table 65. Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 66. Lonza Group Ltd Recent Development Table 67. Boehringher Ingelheim Company Details Table 68. Boehringher Ingelheim Business Overview Table 69. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product Table 70. Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 71. Boehringher Ingelheim Recent Development Table 72. Sandoz Company Details Table 73. Sandoz Business Overview Table 74. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product Table 75. Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 76. Sandoz Recent Development Table 77. Fujifilm Diosynth Biotechnology Company Details Table 78. Fujifilm Diosynth Biotechnology Business Overview Table 79. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product Table 80. Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 81. Fujifilm Diosynth Biotechnology Recent Development Table 82. Rentschler Biotechnologie Company Details Table 83. Rentschler Biotechnologie Business Overview Table 84. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product Table 85. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 86. Rentschler Biotechnologie Recent Development Table 87. Celonic GmbH Company Details Table 88. Celonic GmbH Business Overview Table 89. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Table 90. Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 91. Celonic GmbH Recent Development Table 92. BIOMEVA GmbH Company Details Table 93. BIOMEVA GmbH Business Overview Table 94. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product Table 95. BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 96. BIOMEVA GmbH Recent Development Table 97. ProBioGen AG Company Details Table 98. ProBioGen AG Business Overview Table 99. ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million) Table 100. ProBioGen AG Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type: 2020 VS 2027 Figure 2. Mammalian Based Manufacturing Features Figure 3. Microbial Based Manufacturing Features Figure 4. Other Features Figure 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2020 VS 2027 Figure 6. Bio-Pharmaceutical Companies Case Studies Figure 7. Pharmaceutical Companies Case Studies Figure 8. Drug Discovery Companies Case Studies Figure 9. Other Case Studies Figure 10. Biopharmaceutical Contract Manufacturing(BCMO) Report Years Considered Figure 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions: 2020 VS 2027 Figure 14. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2022-2027) Figure 15. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players in 2020 Figure 16. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2020 Figure 18. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2016-2021) Figure 19. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2022-2027) Figure 20. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027) Figure 22. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027) Figure 23. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027) Figure 24. United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027) Figure 28. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027) Figure 29. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027) Figure 30. Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027) Figure 38. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027) Figure 39. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Region (2016-2027) Figure 40. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027) Figure 48. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027) Figure 49. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027) Figure 50. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027) Figure 54. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027) Figure 55. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027) Figure 56. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Lonza Group Ltd Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 60. Boehringher Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 61. Sandoz Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 62. Fujifilm Diosynth Biotechnology Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 63. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 64. Celonic GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 65. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 66. ProBioGen AG Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Lonza Group Ltd Boehringher Ingelheim Sandoz Fujifilm Diosynth Biotechnology Rentschler Biotechnologie Celonic GmbH BIOMEVA GmbH ProBioGen AG
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients